General Updates

June 19, 2026 To To Listing Department, The Corporate Relations Department NATIONAL STOCK EXCHANGE OF INDIA LIMITED BSE LIMITED Exchange Plaza, Phiroz Jeejeebhoy Towers, Bandra Kurla Complex, Bandra (E), 25th floor, Dalal Street, MUMBAI -400 051 MUMBAI -400 001 Company Code No. AUROPHARMA Company Code No. 524804 Dear Sir/ Madam, Sub: Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Ref : Our letter dated July 30, 2025. We refer to our letter dated July 30, 2025 informing that Aurobindo Pharma USA Inc., a wholly owned subsidiary of the Company, entered into a definitive agreement with LANNETT SELLER HOLDCO, INC under which Aurobindo Pharma USA Inc will acquire 100% of membership interest in Lannett Company LLC from LANNETT SELLER HOLDCO, INC. In this regard, we are pleased to inform you that the necessary approval from US Federal Trade Commission (FTC) for the acquisition of the Lannett business has been obtained today. We anticipate that the transaction will close before the end of this month and will keep the exchanges informed if any future developments in this matter. Please take the above information on record. Thanking you, Yours faithfully, For AUROBINDO PHARMA LIMITED B. Adi Reddy Company Secretary Corp. Off.: Galaxy, Floors: 22-24, Plot No.1, Survey No.83/1, Hyderabad Knowledge City, Raidurg Panmaktha, Ranga Reddy District, Hyderabad – 500 032, Telangana, India. Tel : +91 40 6672 5000 / 6672 1200 Fax: +91 40 6707 4044. Regd. off.: Plot No. 2, Maithrivihar, Ameerpet, Hyderabad - 500 038 Telangana., India Tel: +91 40 2373 6370/ 2374 7340 Fax: +91 40 2374 1080 / 2374 6833 Email: info@aurobindo.com Website: www.aurobindo.com